Cohesive Care Team Ups Health Benefit of EHR Use in Diabetes

Share this content:
Cohesive Care Team Ups Health Benefit of EHR Use in Diabetes
Cohesive Care Team Ups Health Benefit of EHR Use in Diabetes

TUESDAY, Dec. 29, 2015 (HealthDay News) -- Electronic health record (EHR)-related health improvement is greater for patients with diabetes cared for by primary care teams with higher cohesion, according to a study published online Dec. 10 in the American Journal of Managed Care.

Ilana Graetz, Ph.D., from the University of Tennessee Health Science Center in Memphis, and colleagues conducted a retrospective longitudinal study to examine whether team cohesion among primary care team members impacts the association between EHR use and changes in clinical outcomes for patients with diabetes. Provider-reported primary care team cohesion was combined with laboratory values for patients with diabetes and collected during 2005 to 2009, in the period of staggered EHR implementation. Changes in glycated hemoglobin (A1C) and low-density lipoprotein cholesterol (LDL-C) were measured for 80,611 patients with diabetes.

The researchers found that for patients with higher-cohesion primary care teams, EHR use correlated with an average decrease of 0.11 percent for A1C, compared with a 0.08 percent decrease for patients with lower-cohesion teams. EHR use correlated with a decrease of 2.15 mg/dL for LDL-C for patients with higher-cohesion primary care teams, compared with a decrease of 1.42 mg/dL for patients with lower-cohesion teams.

"Patients cared for by higher-cohesion primary care teams experienced modest but statistically significantly greater EHR-related health outcome improvements, compared with patients cared for by providers practicing in lower-cohesion teams," the authors write.

Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »